After success with its BabySat system, Owlet gains FDA clearance for its Dream Sock

November 10, 2023

AbbVie Licenses Ex-China Rights to RemeGen’s PD-1/VEGF Bispecific RC148 for $650 Million Upfront

January 14, 2026

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

April 18, 2026

Must Read

Top 10 High-Impact Careers Defining the Future of Life Sciences

May 1, 2026

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

May 1, 2026

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

May 1, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Oruka Therapeutics Reports Phase 2a Psoriasis Data Showing 63.5% Skin Clearance with ORKA-001

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Teva Pens Deal Worth Over $700M to Buy Emalex

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 High-Impact Careers Defining the Future of Life Sciences

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Tag: Epipen

Pfizer to cough up $345 million to resolve lawsuits over EpiPen price hikes.

Editor Picks

After success with its BabySat system, Owlet gains FDA clearance for its Dream Sock

AbbVie Licenses Ex-China Rights to RemeGen’s PD-1/VEGF Bispecific RC148 for $650 Million Upfront

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Must Read

Top 10 High-Impact Careers Defining the Future of Life Sciences

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Hot Topics

About Us

Follow Us